Replies to post #3353 on Biostax Corp (BTAX)

[noreen]

2. Payment of principal aggregating $286,000 on certain promissory notes issued between November 26, 2014 and September 30, 2016, to raise up to $2,000,000 in debt, on which lenders earn interest at a rate of 10% per annum, plus a pro-rata share of 2 percent of the Company’s gross receipts for sales of IRT-103-LDN in perpetuity.

This is old news. Also, it is 2% of IRT-103. Specifically, it's referring to sales of LDN in the United States through Cytocom. It does not include 2% of sales in Africa for LDN. Someone can correct me if I'm wrong.

Nothing seems out of the ordinary with a 2% royalty here in my opinion.